3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
52
Carcinoma, Renal Cell
25
Liver Neoplasms
23
Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
16
Kidney Neoplasms
11
Leukemia, Myeloid, Acute
9
Melanoma
8
Glioblastoma
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Gliosarcoma
5
Urinary Bladder Neoplasms
4
Recurrence
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Carcinoma
4
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leiomyosarcoma
3
Interventions
Mitotane
4
Cisplatin
3
pembrolizumab
2
cixutumumab
2
Etoposide
2
Doxorubicin
2
Dichlorodiphenyldichloroethane
2
sodium thiosulfate
1
relacorilant
1
pegfilgrastim
1
milademetan
1
gossypol acetic acid
1
cabozantinib
1
avelumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Sunitinib
1
Streptozocin
1
Platinum
1
Nivolumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
Ethane
1
Cytoreduction Surgical Procedures
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adrenocortical Carcinoma
×
Sorafenib
×
Clear all
No trials found.